Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,108
+$1,521 QoQ
Shares Held
330
+69.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#215
of 263 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Derivatives in NVAX
reported options exposure · as of Sep 30, 2020CallValue
$3,000
CallShares
300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Larson Financial Group LLC holds $5,560,518 across 194 Biotechnology names. NVAX ranks #108 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,302 | $646,742 | |
| 2 | INCY |
Incyte Corp
|
4,050 | $459,108 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
7,292 | $400,622 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
627 | $390,959 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,507 | $245,225 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
3,000 | $237,870 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
613 | $184,531 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
709 | $170,847 |
All Filings in NVAX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,108 | 330 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,587 | 195 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,310 | 195 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $4,794 | 553 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,719 | 273 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,282 | 200 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,672 | 208 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,526 | 200 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,532 | 200 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $956 | 200 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $960 | 200 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,448 | 200 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $1,486 | 200 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $5,994 | 865 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $8,892 | 865 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $15,743 | 865 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $44,486 | 865 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $63,707 | 865 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $124,613 | 871 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $160,872 | 776 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $164,752 | 776 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $109,511 | 604 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $34,010 | 305 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $3,000 | 300 | Call | Sole | 2020-10-08 | |
| 2020-03-31 | $556 | 41 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||